Dr. David Maxwell Kleinman, MD

Dr. Kleinman practices at Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center.

Dr. Kleinman's NPI, 1568457752, was assigned on September 14, 2005. Dr. Kleinman graduated from University of Colorado School of Medicine in 1993. Dr. Kleinman holds New York license 226139.

Dr. Kleinman's primary practice is Strong Memorial Hospital, at 601 Elmwood Ave, Rochester, NY 14642 in Monroe County. The practice phone is (585) 275-2121.

Dr. Kleinman's primary practice is Strong Memorial Hospital in Rochester, New York, part of University of Rochester Medical Center. The medical group on file is University of Rochester Medical Faculty Group (URMFG). Dmand AI also links Dr. Kleinman to 2 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kleinman practices. Vendor and product names are available with a free account.

Ophthalmology is Dr. Kleinman's primary specialty in the NPI Registry, under taxonomy code 207W00000X. Dr. Kleinman is licensed in New York.

CMS data shows 416 Medicare services from Dr. Kleinman across 5 procedure codes in 2024, for 85 Medicare patients. Medicare paid $17,220 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 85 Medicare patients who saw Dr. Kleinman in 2024. The largest group is 75 to 84, with 30 patients. 75% of them have high blood pressure, and 69% have high cholesterol. 28% are also on Medicaid. Their average risk score is 1.72, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kleinman's median patient age at 71, with 56% women.

In 2024, Dr. Kleinman wrote 50 Medicare Part D claims for 18 patients. 52% of them were for generic drugs. CMS names the drug for 15 of them, across 1 drug with 11 or more claims each, at $506 in total drug cost. In 2022, CMS named 56 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Kleinman for performance year 2024, reported as part of a group. Dr. Kleinman accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 179 general payments to Dr. Kleinman from 10 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 98% of the total. GlaxoSmithKline, LLC. paid the most, $651,750.

Dr. Kleinman graduated from University of Colorado School of Medicine in 1993.